Keel Point LLC Buys 176 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Keel Point LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,011 shares of the healthcare conglomerate’s stock after acquiring an additional 176 shares during the quarter. Keel Point LLC’s holdings in UnitedHealth Group were worth $2,112,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in UNH. Robbins Farley bought a new position in UnitedHealth Group in the 3rd quarter worth about $25,000. Richelieu Gestion SA purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC raised its holdings in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA grew its stake in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Stephens reiterated an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a report on Thursday, February 8th. Barclays initiated coverage on UnitedHealth Group in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 target price on the stock. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price target for the company in a report on Thursday, April 4th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $573.80.

UnitedHealth Group Stock Up 1.7 %

Shares of NYSE:UNH traded up $7.26 during midday trading on Monday, hitting $446.46. 3,498,704 shares of the stock were exchanged, compared to its average volume of 4,278,967. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The business’s fifty day simple moving average is $492.29 and its two-hundred day simple moving average is $516.34. The company has a market capitalization of $411.60 billion, a PE ratio of 18.74, a P/E/G ratio of 1.20 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.98 by $0.18. The company had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue was up 14.1% compared to the same quarter last year. During the same period last year, the business posted $5.34 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.7 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.68%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 31.54%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.